Agreement with a visiting researcher: An agreement between the university and another educational institution or party that sets out the terms and conditions to be followed while a faculty member attends the other institution. This type of agreement is used to facilitate the college`s ordering of certain professional services from a third party. These agreements are not intended to carry out research or new work, but only to analyse, process, manufacture or provide expertise. All results are the property of the College without the Councillor being entitled to any right of use. These agreements are not suitable for a research sub-agreement or collaboration. For work in which at least one other research partner is involved in a project, a cooperation agreement is required. Materiel Transfer Agreement (TMA): An agreement that governs the transfer of research material between the university and a third party. These agreements are managed by the Office of Technology Management. Awarded as part of a Grand Prize (grant, contract or cooperation agreement) in which part of the scope of work is delegated from the Grand Prize recipient to a sub-recipient. Depending on the circumstances, Mason may be on the transmitter or receiver side of insufficient price.
A Material Transfer Agreement (MTA) is a contract that governs the transfer of research material between two organizations if the recipient intends to use it for its own research purposes. It defines the rights of the parties with regard to the extent of use of the material, confidentiality, publication and ownership of intellectual property. Sometimes a transfer may contain software. Such agreements should not include payment for equipment, with the exception of reimbursement of transport costs. Consortium Agreement: An agreement that governs the conditions for joining a consortium. Research and Development Cooperation Agreement (CASR): A legal agreement between a federal laboratory and the university to collaborate on a project. The agreement does not involve the transfer of funds from the government. A CRADA allows the federal government and the university to optimize their resources, share technical expertise and share the intellectual property that results from the efforts. CRADAS are used by federal laboratories to provide facilities, equipment, personnel, services or other non-monetary resources to support a collaborative research effort. Sponsored Research Agreement (MRA): An agreement entered into directly with a for-profit company that funds a preclinical or non-clinical research project.
An RAS can be funded by for-profit organizations (for example. B, the private sector) or non-profit (federal or state government, foundations, etc.). Sponsors are supported. This type of agreement will be used for clinical trials taking place at sites outside Imperial College and, in the absence of a formalised global agreement with the NHS competent authority, will also be used for clinical trials within the college-linked NHS Trusts (Royal Brompton and Harefield, Chelsea and Westminster, North West London Hospitals, Imperial College Healthcare NHS Trust). If the college is the sponsor of a multi-centre study, it must enter into an agreement with each participating site (usually a university or NHS trust). The agreement guarantees that the site undertakes to comply with the relevant laws, regulations and codes of conduct applicable to the conduct of the study (Research Governance Framework for Health and Social Care/UK Medicines for Human Use (Clinical Trials) Regulations). It contains provisions such as security reports, insurance/liability, medical confidentiality, intellectual property, publications, funding where applicable, etc. A sponsorship agreement is a simplified version of a single clinical trial site participation agreement that is suitable for less complex non-IMP (experimental studies) studies.
The agreement is signed between the sponsor and the participating site and confirms the college`s overall responsibility as a legal sponsor and describes the site`s specific responsibilities with respect to the study (i.e., referral or recruitment of patients to the college). A non-disclosure agreement (NDA), sometimes referred to as a confidential disclosure agreement (CDA) or information ownership agreement (PIA), is a legal agreement between at least two parties that describes confidential documents or knowledge that the parties wish to share with each other for specific purposes but wish to restrict general use. This type of agreement is used for the release of an investigational drug (PMI) by a qualified person (QP) before use. The agreement ensures that the sponsor complies with the applicable EU clinical trial directives (Article 51 of Directive 2001/83/EC, Article 55 of Directive 2001/82/EC) / UK legislation on medicinal products for human use. The PSO contract team uses other tools to facilitate research on behalf of Mason researchers. These agreements serve very specific purposes and can be adapted to particular circumstances as needed. An AOR (Distribution of Rights) document is a non-monetary agreement that establishes rights between the parties to existing (background) and future (foreground) intellectual property. In general, pi is addressed in funding agreements in conjunction with the rest of the conditions. If intellectual property rights need to be defined before an assignment document, an AOR is used. An AOR generally grants each party the use of the intellectual PROPERTY of the project not exclusively and without compensation for the execution of the project. This also includes the possibility of negotiating an exclusive license in a separate agreement.
If you submit an SBIR or STTR proposal, an AOR is required before a signed commitment is provided to the company. This is necessary to ensure that all background IP is identified and protected, while setting rights on the new IP. Since the SBIR and STTR proposals are funded by the federal government, the Bayh Dole Act is used under 37 CFR 401, which specifies what we invent, what we own, what you invent, what you own, and jointly created inventions are jointly owned. This is an agreement that governs how confidential information, including intellectual property, may be disclosed from one party to another. The agreement sets out the conditions for disclosure and whether the information will be returned to the supplier or destroyed upon request. Confidential information includes any information, results or know-how that belongs to someone and that the owner wants to keep secret. The disclosure of confidential information requires that a confidentiality agreement be signed before discussions take place. In other words, it is a contract in which the parties undertake not to disclose the information covered by the agreement. Therefore, a non-disclosure agreement can protect non-public information of various types. Non-disclosure agreements can be „mutual,“ meaning that both parties plan to share confidential information with the other, or they can be unilateral, meaning that only one party discloses confidential information.
A definition of the clinical trial agreement describes the relevant terms and obligations that apply to all parties when a clinical trial is conducted. The agreement must be fully executed before the study is activated. Investigator-led trials are designed by academics and usually sponsored by their employer. These studies are funded by grants from charities, research councils, government agencies, etc., or with the support of pharmaceutical companies. If a pharmaceutical company provides funding (and in some cases drugs free of charge), an agreement must be entered into between the college and the company to ensure that each party agrees to comply with the laws, regulations and codes of conduct applicable to the conduct of the study. The agreement contains provisions on the supply of medicines, financing, safety reports, insurance/liability, publications, intellectual property, etc. A fully funded student body is an agreement to provide funds to a student for research at the doctoral or master`s level. The student will conduct most of the research under academic supervision.
The goal of the research is the doctoral program itself and, ultimately, the awarding of a degree to the student. The funder covers tuition fees and scholarships/scholarships, as well as all necessary consumables/equipment/travel expenses. Funding often comes from industry and government departments, but can also come from other sources. A letter of intent is usually used as confirmation of the agreed terms when an oral agreement is reduced to the written agreement. It sets out the basic principles and guidelines by which the parties will work together to achieve their objectives. It is uniquely tailored to each individual circumstance and can be funded or not. It is also known as a Memorandum of Understanding. This type of agreement can be initiated by a sponsor or investigator.
A sponsor-initiated clinical trial agreement is required if funding is provided for the drug or device under study. Research Collaboration Agreements (CRAs) are contracts between UTD and one or more organizations that work together to conduct a research program. The agreement describes the actions to which each organization has subscribed and defines the obligations of each party to the other parties involved in the joint research efforts. An agreement for the purpose of acquiring the professional services of a person with knowledge and expertise in a particular field. Consultants are considered independent contractors and not subcontractors or employees. Consulting contracts are not processed in OSP, but are treated as services purchased and coordinated by the Procurement Office. This agreement commits a research partner to a specific set of work as part of a research project (or series of research projects) owned by the college and usually involves payments to the partner. The agreement is often established as a result of a main grant or other research funding agreement and involves discreet and specific work carried out by a partner organisation.